Systemic autoimmune disease as a consequence of defective lymphocyte death

被引:27
作者
Hünig, T [1 ]
Schimpl, A [1 ]
机构
[1] Univ Wurzburg, Inst Virol & Immunbiol, D-97078 Wurzburg, Germany
关键词
D O I
10.1016/S0952-7915(97)80185-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A major group of systemic autoimmune diseases is associated with abnormal lymphoproliferation, as a result of defects in the termination of lymphocyte activation and growth. Recent progress has been made in understanding the causes and consequences of these abnormalities. At the molecular level, the defects in CD95 and its ligand are only the most obvious reasons for the breakdown of 'clonal contraction' which in fact requires the participation of multiple gene products, including the IL-2-IL-2-receptor system, to set up a functional apoptotic machinery.
引用
收藏
页码:826 / 830
页数:5
相关论文
共 59 条
  • [51] Um HD, 1996, J IMMUNOL, V156, P3469
  • [52] VARADHACHARY AS, 1997, P NATL ACAD SCI USA, V94, P6778
  • [53] Induction of sensitivity to activation-induced death in primary CD4(+) cells: A role for interleukin-2 in the negative regulation of responses by mature CD4(+) T cells
    Wang, RD
    Rogers, AM
    Rush, BJ
    Russell, JH
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (09) : 2263 - 2270
  • [54] THE INFLUENCE OF THE IPR GENE ON B-CELL ACTIVATION - DIFFERENTIAL ANTIBODY EXPRESSION IN IPR CONGENIC MOUSE STRAINS
    WARREN, RW
    CASTER, SA
    ROTHS, JB
    MURPHY, ED
    PISETSKY, DS
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1984, 31 (01): : 65 - 77
  • [55] LYMPHOPROLIFERATION DISORDER IN MICE EXPLAINED BY DEFECTS IN FAS ANTIGEN THAT MEDIATES APOPTOSIS
    WATANABEFUKUNAGA, R
    BRANNAN, CI
    COPELAND, NG
    JENKINS, NA
    NAGATA, S
    [J]. NATURE, 1992, 356 (6367) : 314 - 317
  • [56] INTERLEUKIN-2 RECEPTOR-ALPHA CHAIN REGULATES THE SIZE AND CONTENT OF THE PERIPHERAL LYMPHOID COMPARTMENT
    WILLERFORD, DM
    CHEN, JZ
    FERRY, JA
    DAVIDSON, L
    MA, A
    ALT, FW
    [J]. IMMUNITY, 1995, 3 (04) : 521 - 530
  • [57] Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease
    Wu, JG
    Wilson, J
    He, J
    Xiang, LB
    Schur, PH
    Mountz, JD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (05) : 1107 - 1113
  • [58] Mechanisms of drug-induced lupus .2. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice
    Yung, R
    Powers, D
    Johnson, K
    Amento, E
    Carr, D
    Laing, T
    Yang, J
    Chang, S
    Hemati, N
    Richardson, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) : 2866 - 2871
  • [59] Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis
    Zhang, XH
    Brunner, T
    Carter, L
    Dutton, RW
    Rogers, P
    Bradley, L
    Sato, T
    Reed, JC
    Green, D
    Swain, SL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (10) : 1837 - 1849